Article Details

BXCL701 Earns FDA FTD in Small Cell Neuroendocrine Prostate Cancer

Retrieved on: 2024-02-12 18:52:21

Tags for this article:

Click the tags to see associated articles and topics

BXCL701 Earns FDA FTD in Small Cell Neuroendocrine Prostate Cancer. View article details on hiswai:

Excerpt

Developers are assessing whether treatment with BXCL701 can turn “cold” tumors “hot” and help the adaptive immune system detect them more easily.

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo